---
aliases: >-
  /news/earlitec-diagnostics-raises-19-5m-to-advance-autism-diagnosis-and-treatment-in-children
archetype: curated-content
author:
  - Radhika Narayanan
basePath: /news/
breadcrumbLinks:
  - /
  - /news/
  - ''
breadcrumbs:
  - Home
  - News
  - >-
    EarliTec Diagnostics Raises $19.5M to Advance Autism Diagnosis and Treatment
    in Children
categories:
  - 'Standard Occupational Classification (SOC): Fundraisers'
categorySlug:
  - 'standard occupational classification (soc): fundraisers'
categoryUrl:
  - topic/standard-occupational-classification-soc-fundraisers
categoryLabel:
  - Fundraisers
contentCategories: netspective-medigy-news-curated-content
institution: null
offering: null
layOut: single
date: '2022-02-21'
description: >-
  EarliTec Dx raises $19.5M for products for children with Autism Spectrum
  Disorder (ASD) and early childhood vulnerabilities,This round of financing
  will be used to support filing with the U.S. Food an
favIconImage: null
featuredImage:
  alt: >-
    EarliTec Diagnostics Raises $19.5M to Advance Autism Diagnosis and Treatment
    in Children
  format: JPEG
  href: aea62f39-be89-5948-a3e4-b749c65ec6d9-featuredImage.jpeg
  size:
    - 682
    - 1024
  valid: true
  workPackage: 11541
  wpAttachment:
    fileName: Curated_Featured_Image.jpg
    link: /api/v3/attachments/21821/content
featuredPdf: null
htmlMetaData:
  author: null
  description: null
  generator: null
  viewport: null
  articlemodified_time: null
  articlepublished_time: null
  msvalidate.01: null
  ogdescription: >-
    EarliTec Dx raises $19.5M for products for children with Autism Spectrum
    Disorder (ASD) and early childhood vulnerabilities,
  ogimage: null
  ogsite_name: null
  ogtitle: >-
    EarliTec Diagnostics Raises $19.5M to Advance Autism Diagnosis and Treatment
    in Children
  ogtype: null
  ogupdated_time: null
  ogurl: null
  yandex-verification: null
  robots: null
  fbapp_id: null
  oglocale: null
  fbadmins: null
  articlepublisher: null
  google-site-verification: null
  keywords: null
id: 11541
identifier: News
lastMod: '2022-02-21T22:38:30.451322Z'
link:
  brand: hitconsultant.net
  href: 'https://hitconsultant.net/2022/02/18/earlitec-diagnostics-autism-diagnosis/'
  original: 'https://hitconsultant.net/2022/02/18/earlitec-diagnostics-autism-diagnosis/'
href: 'https://hitconsultant.net/2022/02/18/earlitec-diagnostics-autism-diagnosis/'
original: 'https://hitconsultant.net/2022/02/18/earlitec-diagnostics-autism-diagnosis/'
mastHead: NEWS
mdName: aea62f39-be89-5948-a3e4-b749c65ec6d9.md
openGraphMetaData:
  ogdescription: >-
    EarliTec Dx raises $19.5M for products for children with Autism Spectrum
    Disorder (ASD) and early childhood vulnerabilities,
  ogtitle: >-
    EarliTec Diagnostics Raises $19.5M to Advance Autism Diagnosis and Treatment
    in Children
  ogurl: null
  ogimage: null
  ogsite_name: null
  ogtype: null
  ogupdated_time: null
  ogimageheight: null
openProjectCustomFields:
  cleanUrl: 'https://hitconsultant.net/2022/02/18/earlitec-diagnostics-autism-diagnosis/'
  medigyTopics:
    - 'Standard Occupational Classification (SOC): Fundraisers'
  sourceUrl: 'https://hitconsultant.net/2022/02/18/earlitec-diagnostics-autism-diagnosis/'
openProjectWorkPackageType: Curated Content
searchCategory: News
slug: >-
  hitconsultant-earlitec-diagnostics-raises-19-5m-to-advance-autism-diagnosis-and-treatment-in-children
source: open-project-curations
status: ''
sub: brief
tags:
  - News
title: >-
  EarliTec Diagnostics Raises $19.5M to Advance Autism Diagnosis and Treatment
  in Children
via: ' '
insights_description: null
insights_name: null
viaLink: null
relatedOfferings: null
twitterMetaData:
  twittercard: null
  twitterdescription: >-
    EarliTec Dx raises $19.5M for products for children with Autism Spectrum
    Disorder (ASD) and early childhood vulnerabilities,
  twittertitle: >-
    EarliTec Diagnostics Raises $19.5M to Advance Autism Diagnosis and Treatment
    in Children
  twitterimage: null
  twitterurl: null
---
<p>EarliTec Dx raises $19.5M for products for children with Autism Spectrum Disorder (ASD) and early childhood vulnerabilities,<br><br>This round of financing will be used to support filing with the U.S. Food and Drug Administration (FDA) for 510K clearance, as well as commercialization of the company’s first product, the EarliPoint® Evaluation for ASD, which received breakthrough status in April 2021.
With technology developed by leading researchers at Children’s Healthcare of Atlanta, Emory University School of Medicine and Yale University, the company has completed clinical trials with more than 1,500 children—receiving breakthrough status for the EarliPoint® system in April of last year.</p>